No close equivalent identified in the reviewed prior work.
Summary
Eight claims were assessed before public framing.
Related prior approaches exist, but the implementation differs.
No public claims were withdrawn after review.
Claims were frozen before the prior-work search.
Preferred public statement
We did not identify a close prior approach in the literature and institutional work we reviewed that combines a frozen edge-level public-traceability framework across the AMR commitment-to-progress chain with claim-level reproducibility.
This is a bounded prior-work assessment, not a claim of first-ever invention.
Language we never use
- First-ever.
- Unprecedented.
- Unique.
- World-first.
- First to discover.
- First evidence ledger in AMR.
AMR Research & Method
Claims related to AMR policy analysis and public evidence traceability.
NC-02Public traceability is separated from national AMR implementation performance.A- · No close equivalentHow we describe it
We explicitly separate public evidence traceability from national AMR implementation performance. In the prior work we reviewed, we did not identify multi-country assessments making this separation explicit at the methodology level.
How we do not describe it
First to discover implementation-performance separation.
NC-05Claim-level reproducibility links reported relationships to source, locator and evidence status.A- · No close equivalentHow we describe it
We provide claim-level reproducibility through an evidence ledger. In the prior work we reviewed, we did not identify AMR multi-country assessments linking every reported relationship to source, locator and evidence status.
How we do not describe it
First evidence ledger in AMR research.
NC-01Frozen edge-level traceability across the AMR commitment-to-progress chain.B+ · Related prior approachesHow we describe it
Our approach applies a frozen edge-level traceability method across the AMR policy-to-outcome chain. In the prior work we reviewed, multi-country assessments used self-reporting or literature synthesis, not independent public evidence traceability at specific edges with claim-level provenance.
How we do not describe it
First-ever, unique or unprecedented cross-country AMR traceability method.
NC-03NOT_ASSESSED and BROKEN are separate evidence states.B+ · Related prior approachesHow we describe it
Our four-class edge taxonomy is adapted for AMR policy-to-outcome relationships. Implementation science provides related conceptual frameworks, but we did not identify AMR-specific applications at the relationship level in the prior work we reviewed.
How we do not describe it
First four-class taxonomy in AMR.
NC-04Cross-country reconstruction uses a frozen, pre-specified edge methodology.B · Related prior approachesHow we describe it
We use a frozen pre-specified methodology where edge definitions are established before analysis. This differs from flexible self-assessments or adaptive systematic reviews used in prior AMR multi-country work.
How we do not describe it
First frozen methodology in AMR assessment.
NC-08Public evidence traceability weakens toward outcome and progress measurement.B+ · Related prior approachesHow we describe it
Our assessment shows a systematic pattern in public evidence traceability across the AMR implementation chain. Prior work identified implementation barriers, but we did not identify edge-level quantification of this decay pattern across countries in the prior work we reviewed.
How we do not describe it
First discovery of AMR evidence decay.
AgentBrain System Architecture
Claims related to governed agent production and persistent research context.
NC-06Evidence-gated multi-agent production keeps publication under human control.B+ · Related prior approachesHow we describe it
Our system separates multi-agent evidence production from human-controlled publication. While multi-agent frameworks exist, we did not identify equivalent governance separation in health policy research systems in the prior work we reviewed.
How we do not describe it
First agent system with human gate.
NC-07Persistent cross-run memory supports continuity across research sessions and model changes.B · Related prior approachesHow we describe it
Our system maintains persistent research context across separate sessions and model changes. This differs from session-bound memory in standard agent frameworks.
How we do not describe it
First persistent agent memory.
Prior work consulted
Institutional: WHO GLASS, TrACSS, OECD AMR reports, Global AMR R&D Hub, Wellcome and Fleming Fund material.
Scientific and agent systems: PubMed, Google Scholar, implementation-science literature, AutoGen, LangGraph, CrewAI and multi-agent governance research.
Limitations
English-focused review, no subscription access to Scopus or Web of Science, grey literature incomplete and publication lag possible.
Institutional: WHO GLASS, TrACSS, OECD AMR reports, Global AMR R&D Hub, Wellcome and Fleming Fund material.
Scientific and agent systems: PubMed, Google Scholar, implementation-science literature, AutoGen, LangGraph, CrewAI and multi-agent governance research.
Limitations
English-focused review, no subscription access to Scopus or Web of Science, grey literature incomplete and publication lag possible.